HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary artery lesion-based plaque volume, according to a study ...

A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...

As Elon Musk moves to shutter the U.S. Agency for International Development, the agency’s support for the discovery of novel ...

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field: Shelton, Connecticut Thursda ...

President Trump is reportedly preparing an executive order to halt funding of risky viral gain-of-function research—lab ...

Although the number of influenza-like illnesses per 100,000 inhabitants was higher than on the 6th week of 2025 only once in ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

On Thursday 13 February 2025, the Health Directorate of Luxembourg's Ministry of Health and Social Security published its ...

The confirmation of Robert F. Kennedy, Jr. as Trump’s Health Secretary marks a critical milestone in the deepening war on ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

Q3 2025 Earnings Call Transcript February 12, 2025 Aethlon Medical, Inc. beats earnings expectations. Reported EPS is $-0.13, ...